SEC pushes cyber resilience frameworks for capital markets InsiderPH

Johnson & Johnson’s hematology portfolio: breakthroughs to watch
Today’s guest is J&J’s Ester in t’Groen and we will discuss what’s next for J&J in hematology in 2026—including some exciting readouts. The post Johnson


